CNS Pharmaceuticals Inc. (CNSP)
0.10
-0.00 (-3.47%)
At close: Jan 29, 2025, 3:59 PM
0.10
0.00%
After-hours Jan 29, 2025, 07:58 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -18.85M | -15.27M | -14.04M | -9.46M | -3.88M | -7.39M | -219.36K |
| Depreciation & Amortization | 4.13K | 11.76K | 13.07K | 11.10K | 1.96K | n/a | n/a |
| Stock-Based Compensation | 1.01M | 1.20M | 1.72M | 1.29M | 477.10K | 110.24K | 119.85K |
| Other Working Capital | 2.38M | 1.46M | -1.82M | 176.95K | -579.23K | 12.41K | -10.25K |
| Other Non-Cash Items | 498.00 | 337.25K | 714.87K | 1.58K | 270.31K | 6.48M | 2.42K |
| Deferred Income Tax | n/a | n/a | -714.87K | n/a | n/a | n/a | n/a |
| Change in Working Capital | 3.70M | 3.16M | -1.24M | 833.78K | -425.62K | 83.78K | 47.25K |
| Operating Cash Flow | -14.14M | -10.56M | -13.54M | -7.32M | -3.55M | -716.38K | -112.20K |
| Capital Expenditures | -3.90K | -4.42K | -5.75K | -17.95K | -20.12K | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -3.90K | -4.42K | -5.75K | -17.95K | -20.12K | n/a | n/a |
| Debt Repayment | -438.73K | n/a | n/a | -43.08K | -35.00K | 300.00K | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 2.76M | 15.61M | 4.51M | -45.00K | n/a | 860.98K | 222.74K |
| Financial Cash Flow | 4.64M | 15.61M | 4.51M | 14.13M | 10.26M | 1.16M | 222.74K |
| Net Cash Flow | -9.51M | 5.05M | -9.03M | 6.80M | 6.69M | 444.59K | 110.54K |
| Free Cash Flow | -14.14M | -10.56M | -13.54M | -7.34M | -3.57M | -716.38K | -112.20K |